Quick SearchStructure Search
Drug News & Perspectives
Register or sign in

 
  
Drug News Perspect 2003, 16(4): 217
ISSN 0214-0934
Copyright 2003 Prous Science
CCC: 0214-0934
 

Determining toxicological potential in new chemical entities early on in development would be highly useful in streamlining and reducing the cost of drug development.

Application of Toxicogenomics in Drug Development

by Timothy W. Gant


Summary

The recognition of toxicological potential in new chemical entities early on in development would be highly desirable in streamlining and reducing the cost of drug development. Analysis of gene expression profiles using microarrays is one of the most fashionable methods for achieving this objective. The procedure relies on developing a gene expression profile related to compound exposure and then matching this against a database of profiles associated with known mechanisms of toxicity. Studies profiling tumors and associating these with pathology and phenotype have shown the potential of the technique. However, application of the technique in toxicology is only at the preliminary stage. This article examines current state of development in toxicology and its future potential. © 2003 Prous Science. All rights reserved.



Full Text: HTMLPDF 
 
  



Copyright © Prous Science, S.A.U. or its licensors. All rights reserved.
Legal Information.